anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Quote

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 18,554
Current window 7,201-7,230
Pages 619
Rows per page 30
Component: Quoteclear collectionreset all
18 30 60

Component

7,201-7,230 of 18,554

filter-aware
188
Uses a quote from a VW employee to undermine the company's timeline.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction2 hits
04
The slide uses a direct user testimonial to highlight product safety concerns.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
06
The slide uses a social media post as a testimonial to highlight negative patient outcomes.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
33
Uses a CEO quote to highlight a potential contradiction between management narrative and market reality.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
35
The slide uses a Q&A transcript format to build a narrative of a cover-up regarding drug safety.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
59
Soleno Therapeutics (SLNO)Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
98
The slide uses a direct quote to highlight the physician's negative sentiment regarding the drug's value proposition versus the administrative effort required.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
110
The slide uses a Q&A transcript format to highlight specific patient cases that suggest a severe, long-term adverse effect.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
136
The slide uses a 'two-hit' metaphor to describe the synergistic risk of the two medications.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
150
The slide uses a direct quote from a physician to undermine the company's marketing claims.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
188
The slide uses a 'quote-highlight' structure to emphasize specific allegations of misconduct.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
207
The slide presents a Q&A transcript excerpt highlighting potential fraud and competitive threats.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
215
The slide uses a Q&A format to validate the thesis that MDCalc is a key driver for off-label drug substitution.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
224
The slide uses a Q&A transcript format to highlight negative sentiment from former employees.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
227
The slide uses a combination of a summary paragraph and a direct verbatim quote with highlighted sections.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
228
The slide uses a Q&A transcript format to highlight the alleged suppression of negative clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
234
The slide uses a long, narrative-style headline that summarizes the ex-employee's critique, followed by a highlighted block quote.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
236
The slide uses a direct quote from an ex-employee to undermine the clinical value proposition of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
241
The slide uses a quote to establish credibility and validate the activist's research findings.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
243
The slide uses a Q&A format to validate the primary claim made in the headline.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
245
The slide uses a 'quote-summary' structure to undermine the company's launch narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
246
The slide uses a Q&A format to present expert testimony.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
253
The slide uses a quote to undermine the credibility of the company's clinical trial data by highlighting the difference between controlled trial environments and real-world application.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
257
The slide uses a Q&A format to present expert testimony that undermines the value proposition of the drug Vykat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
261
The slide uses a quote to highlight potential ethical or professional concerns regarding a physician's promotion of a drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
285
The slide uses a Q&A format to present expert opinion as evidence of safety risks.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
290
The slide uses a Q&A format to highlight allegations of 'artificial enrollment' and data manipulation.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
295
The slide uses a Q&A transcript format to highlight negative sentiment from a key opinion leader.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
306
The slide uses a Q&A format to present qualitative evidence from a trial investigator.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
307
The slide uses a Q&A format to highlight the investigator's skepticism.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits